Biotech and Pharmaceuticals

Stocks today: Live updates

Business
Jessica Roberts

19 Mins Ago Stocks fall after GDP data shows slowing economic growth Stocks opened lower on Thursday, with equities selling off after ...

3.6 million Medicare patients could get heart health coverage

Health
Rachel Carter

Medicare’s budget could be strained as more plans cover the costs of Wegovy. The program’s prescription drug plans could spend an additional ...

Walgreens (WBA) earnings Q2 2024

Business
Jessica Roberts

A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, ...

How much people are willing to spend

Health
Rachel Carter

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters ...

Wegovy heart health approval won’t mean broad insurance coverage yet

Health
Rachel Carter

Some employers and other health plans are still reluctant to cover Wegovy due to its hefty $1,350 monthly price tag, which they ...

Eli Lilly (LLY) earnings Q4 2023

Business
Jessica Roberts

Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.  Mike Blake | ...

New York AG pushing for lifetime Trump ban cites Martin Shkreli ruling

Trending
Sarah Wilson

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, exits court in New York, US, on Wednesday, Oct. 4, 2023.  Yuki ...

US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder

Business
Jessica Roberts

The headquarters of US biopharmaceutical company Vertex Pharmaceuticals in Boston, Massachusets, on November 4, 2023. Joseph Prezioso | Afp | Getty Images ...

Health sector themes to watch in 2024

Business
Jessica Roberts

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | ...

Pharma had a year full of firsts

Health
Rachel Carter

Soumyabrata Roy | Nurphoto | Getty Images The Alzheimer’s disease space also got plenty of attention, with the approval and launch of ...